BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1706539)

  • 1. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: regeneration studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):58-66. PubMed ID: 1706540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine triphosphate protection of chlordecone-amplified CCl4 hepatotoxicity and lethality.
    Soni MG; Mehendale HM
    J Hepatol; 1994 Feb; 20(2):267-74. PubMed ID: 7516359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of calcium homeostasis leads to progressive phase of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Kodavanti PR; Rao VC; Mehendale HM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):77-87. PubMed ID: 7690997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dietary exposure to a mirex plus chlordecone combination on CCl4 hepatotoxicity.
    Bell AN; Mehendale HM
    Fundam Appl Toxicol; 1985 Aug; 5(4):679-87. PubMed ID: 2412926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality by partial hepatectomy.
    Bell AN; Young RA; Lockard VG; Mehendale HM
    Arch Toxicol; 1988 Apr; 61(5):392-405. PubMed ID: 2456051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic failure leads to lethality of chlordecone-amplified hepatotoxicity of carbon tetrachloride.
    Soni MG; Mehendale HM
    Fundam Appl Toxicol; 1993 Nov; 21(4):442-50. PubMed ID: 7504640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of BrCCl3 hepatotoxicity by chlordecone: biochemical and ultrastructural study.
    Faroon OM; Henry RW; Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):185-97. PubMed ID: 1716382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromotrichloromethane hepatotoxicity. The role of stimulated hepatocellular regeneration in recovery: biochemical and histopathological studies in control and chlordecone pretreated male rats.
    Faroon OM; Mehendale HM
    Toxicol Pathol; 1990; 18(4 Pt 2):667-77. PubMed ID: 1709515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality.
    Dalu A; Rao PS; Mehendale HM
    Environ Health Perspect; 1998 Sep; 106(9):597-606. PubMed ID: 9721260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):230-45. PubMed ID: 6194012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of CCl4 hepatotoxicity and lethality by chlordecone in female rats.
    Agarwal AK; Mehendale HM
    Toxicology; 1983; 26(3-4):231-242. PubMed ID: 6190268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative changes in hepatic DNA, RNA, protein, lipid, and glycogen induced by a subtoxic dose of CCl4 in chlordecone, mirex, and phenobarbital pretreated rats.
    Bell AN; Mehendale HM
    Toxicol Lett; 1987 Feb; 35(2-3):191-200. PubMed ID: 2435023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplified interactive toxicity of chemicals at nontoxic levels: mechanistic considerations and implications to public health.
    Mehendale HM
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):139-49. PubMed ID: 7535226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon tetrachloride-induced alterations of hepatic calmodulin and free calcium levels in rats pretreated with chlordecone.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Hepatology; 1991 Feb; 13(2):230-8. PubMed ID: 1704867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a morphometric and biochemical study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):246-55. PubMed ID: 6194013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic polyamines and related enzymes following chlordecone-potentiated carbon tetrachloride toxicity in rats.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1989; 4(1):55-63. PubMed ID: 2475629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.